Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from eastern India. (åbner nyt vindue)

Bohara VV, Ray S, Chakrabarti P, Ray SS, Nath UK, Chaudhuri U.

Kilde‎: Hemoglobin 2014;38(1):44-8.

Indekseret‎: PubMed 24144212

DOI‎: 10.3109/03630269.2013.845844

https://www.ncbi.nlm.nih.gov/pubmed/24144212 (åbner nyt vindue)

Hydroxyurea in thalassemia intermedia--a promising therapy. (åbner nyt vindue)

Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP.

Kilde‎: Ann Hematol 2005;84(7):441-6.

Indekseret‎: PubMed 15838670

DOI‎: 10.1007/s00277-005-1026-4

https://www.ncbi.nlm.nih.gov/pubmed/15838670 (åbner nyt vindue)

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. (åbner nyt vindue)

Italia KY, Jijina FF, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, Nair SB, Ghosh K, Colah RB.

Kilde‎: J Clin Pathol 2010;63(2):147-50.

Indekseret‎: PubMed 20154037

DOI‎: 10.1136/jcp.2009.070391

https://www.ncbi.nlm.nih.gov/pubmed/20154037 (åbner nyt vindue)

Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia. (åbner nyt vindue)

Karimi M, Borzouee M, Mehrabani A, Cohan N.

Kilde‎: Eur J Haematol 2009;82(3):213-8.

Indekseret‎: PubMed 19077048

DOI‎: 10.1111/j.1600-0609.2008.01192.x

https://www.ncbi.nlm.nih.gov/pubmed/19077048 (åbner nyt vindue)

Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia. (åbner nyt vindue)

Karimi M, Mohammadi F, Behmanesh F, Samani SM, Borzouee M, Amoozgar H, Haghpanah S.

Kilde‎: Eur J Haematol 2010;84(1):52-8.

Indekseret‎: PubMed 19799627

DOI‎: 10.1111/j.1600-0609.2009.01356.x

https://www.ncbi.nlm.nih.gov/pubmed/19799627 (åbner nyt vindue)

Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece. (åbner nyt vindue)

Loukopoulos D, Voskaridou E, Kalotychou V, Schina M, Loutradi A, Theodoropoulos I.

Kilde‎: Blood Cells Mol Dis 2000;26(5):453-66.

Indekseret‎: PubMed 11112383

DOI‎: 10.1006/bcmd.2000.0328

https://www.ncbi.nlm.nih.gov/pubmed/11112383 (åbner nyt vindue)

Fetal globin stimulant therapies in the beta-hemoglobinopathies: principles and current potential. (åbner nyt vindue)

Perrine SP.

Kilde‎: Pediatr Ann 2008;37(5):339-46.

Indekseret‎: PubMed 18543545

https://www.ncbi.nlm.nih.gov/pubmed/18543545 (åbner nyt vindue)

Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. (åbner nyt vindue)

Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP.

Kilde‎: Ann N Y Acad Sci 2005;1054:250-6.

Indekseret‎: PubMed 16339672

DOI‎: 10.1196/annals.1345.031

https://www.ncbi.nlm.nih.gov/pubmed/16339672 (åbner nyt vindue)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (åbner nyt vindue)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Kilde‎: Acta Haematol 2004;111(4):189-95.

Indekseret‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (åbner nyt vindue)

Efficacy of erythropoietin on dialysis in patients with beta thalassemia minor. (åbner nyt vindue)

Di Iorio B, De Nicola L, Bellizzi V, Minutolo R, Zamboli P, Rubino R, Fuiano G, Conte G.

Kilde‎: Blood Purif 2004;22(5):453-60.

Indekseret‎: PubMed 15359104

DOI‎: 10.1159/000080729

https://www.ncbi.nlm.nih.gov/pubmed/15359104 (åbner nyt vindue)

The role of recombinant human erythropoietin in the treatment of thalassemia. (åbner nyt vindue)

Rachmilewitz EA, Aker M.

Kilde‎: Ann N Y Acad Sci 1998;850:129-38.

Indekseret‎: PubMed 9668535

https://www.ncbi.nlm.nih.gov/pubmed/9668535 (åbner nyt vindue)

Darbepoetin alfa for the treatment of anaemia in alpha- or beta- thalassaemia intermedia syndromes. (åbner nyt vindue)

Singer ST, Vichinsky EP, Sweeters N, Rachmilewitz E.

Kilde‎: Br J Haematol 2011;154(2):281-4.

Indekseret‎: PubMed 21496003

DOI‎: 10.1111/j.1365-2141.2011.08617.x

https://www.ncbi.nlm.nih.gov/pubmed/21496003 (åbner nyt vindue)

The emerging role of fetal hemoglobin induction in non-transfusion-dependent thalassemia. (åbner nyt vindue)

Thein SL.

Kilde‎: Blood Rev 2012;26 Suppl 1:S35-9.

Indekseret‎: PubMed 22631042

DOI‎: 10.1016/S0268-960X(12)70011-5

https://www.ncbi.nlm.nih.gov/pubmed/22631042 (åbner nyt vindue)